{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:09:35Z","timestamp":1790701775919,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Robert and Patricia Kern Center"},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research and Education Program"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.mayocp.2019.04.005","type":"journal-article","created":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T08:07:16Z","timestamp":1569398836000},"page":"2291-2301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology"],"prefix":"10.1016","volume":"94","author":[{"given":"Rahma","family":"Warsame","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"D\u2019Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/j.mayocp.2019.04.005_bib1","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.1111\/j.1524-4733.2007.00275.x","article-title":"Patient-reported outcomes to support medical product labeling claims: FDA perspective","volume":"10","author":"Patrick","year":"2007","journal-title":"Value Health"},{"issue":"suppl 7","key":"10.1016\/j.mayocp.2019.04.005_bib2","first-page":"iii","article-title":"Overview of adult health measures fielded in Rand\u2019s health insurance study","volume":"17","author":"Brook","year":"1979","journal-title":"Med Care"},{"key":"10.1016\/j.mayocp.2019.04.005_bib3","series-title":"Crossing the quality chasm: a new health system for the 21st century","first-page":"1","year":"2001"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib4","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1002\/cncr.23856","article-title":"Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer","volume":"113","author":"Schnadig","year":"2008","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.mayocp.2019.04.005_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/ajh.24676","article-title":"Hematology patient reported symptom screen to assess quality of life for AL amyloidosis","volume":"92","author":"Warsame","year":"2017","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib6","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1200\/JCO.2007.13.3439","article-title":"The prognostic significance of patient-reported outcomes in cancer clinical trials","volume":"26","author":"Gotay","year":"2008","journal-title":"J\u00a0Clin Oncol"},{"issue":"9","key":"10.1016\/j.mayocp.2019.04.005_bib7","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S1470-2045(09)70200-1","article-title":"Baseline quality of life as a prognostic indicator of survival: a meta-analysis of individual patient data from EORTC clinical trials","volume":"10","author":"Quinten","year":"2009","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.005_bib8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.cct.2009.02.005","article-title":"The use of patient-reported outcomes instruments in registered clinical trials: evidence from ClinicalTrials.gov","volume":"30","author":"Scoggins","year":"2009","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/j.mayocp.2019.04.005_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cct.2015.04.004","article-title":"Inclusion of patient-reported outcome measures in registered clinical trials: Evidence from ClinicalTrials.gov (2007-2013)","volume":"43","author":"Vodicka","year":"2015","journal-title":"Contemp Clin Trials"},{"issue":"14","key":"10.1016\/j.mayocp.2019.04.005_bib10","doi-asserted-by":"crossref","first-page":"i","DOI":"10.3310\/hta2140","article-title":"Evaluating patient-based outcome measures for use in clinical trials","volume":"2","author":"Fitzpatrick","year":"1998","journal-title":"Health Technol Assess"},{"issue":"26","key":"10.1016\/j.mayocp.2019.04.005_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJM198606263142602","article-title":"The effects of antihypertensive therapy on the quality of life","volume":"314","author":"Croog","year":"1986","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.04.005_bib12","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1477-7525-4-79","article-title":"Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance","volume":"4","author":"U.S. Department of Health and Human Services FDA Center for Drug Evaluation and Research","year":"2006","journal-title":"Health Qual Life Outcomes"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.jval.2013.08.2293","article-title":"Assessment of PRO label claims granted by the FDA as compared to the EMA (2006-2010)","volume":"16","author":"Demuro","year":"2013","journal-title":"Value Health"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.005_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1586\/14737167.2013.814957","article-title":"US FDA patient-reported outcome guidance: great expectations and unintended consequences","volume":"13","author":"Fehnel","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.005_bib15","first-page":"34","article-title":"Measuring the value of treatment to patients: patient-reported outcomes in drug development","volume":"1","author":"Willke","year":"2008","journal-title":"Am Health Drug Benefits"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.005_bib16","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jval.2011.11.032","article-title":"A\u00a0review of patient-reported outcome labels in the United States: 2006 to 2010","volume":"15","author":"Gnanasakthy","year":"2012","journal-title":"Value Health"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.005_bib17","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jval.2016.10.006","article-title":"A\u00a0review of patient-reported outcome labeling in the United States (2011\u20132015)","volume":"20","author":"Gnanasakthy","year":"2017","journal-title":"Value Health"},{"issue":"16","key":"10.1016\/j.mayocp.2019.04.005_bib18","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1200\/JCO.2015.63.6480","article-title":"Patient-reported outcomes labeling for products approved by the office of hematology and oncology products of the US Food and Drug Administration (2010-2014)","volume":"34","author":"Gnanasakthy","year":"2016","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.mayocp.2019.04.005_bib19","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamaoncol.2015.0530","article-title":"Patient-Reported outcomes in cancer drug development and US regulatory review: perspectives from industry, the Food and Drug Administration, and the patient","volume":"1","author":"Basch","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.04.005_bib20","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1046\/j.1524-4733.2003.65309.x","article-title":"Incorporating the patient\u2019s perspective into drug development and communication: an ad hoc task force report of the patient-reported outcomes (PRO) Harmonization Group meeting at the food and drug administration, February 16, 2001","volume":"6","author":"Acquadro","year":"2003","journal-title":"Value Health"},{"issue":"10","key":"10.1016\/j.mayocp.2019.04.005_bib21","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1200\/JCO.2012.44.4489","article-title":"Effect of ruxolitinib therapy on myelofibrosis-related symptoms and other patient-reported outcomes in COMFORT-I: a randomized, double-blind, placebo-controlled trial","volume":"31","author":"Mesa","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"6","key":"10.1016\/j.mayocp.2019.04.005_bib22","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","article-title":"Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial","volume":"15","author":"Burris","year":"1997","journal-title":"J\u00a0Clin Oncol"},{"issue":"29","key":"10.1016\/j.mayocp.2019.04.005_bib23","doi-asserted-by":"crossref","first-page":"3711","DOI":"10.1200\/JCO.2013.49.6125","article-title":"End points and trial design in geriatric oncology research: a joint European Organisation for Research and Treatment of Cancer-Alliance for clinical trials in oncology\u2013International Society of Geriatric Oncology position article","volume":"31","author":"Wildiers","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.mayocp.2019.04.005_bib24","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(15)00206-5","article-title":"Prognostic value of self-reported fatigue on overall survival in patients with myelodysplastic syndromes: a multicentre, prospective, observational, cohort study","volume":"16","author":"Efficace","year":"2015","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.005_bib25","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/cncr.29717","article-title":"Patient-reported physiical functioning predicts the success of hematopoietic cell transplantation (BMT CTN 0902)","volume":"122","author":"Wood","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.mayocp.2019.04.005_bib26","series-title":"Common Terminology Criteria for Adverse Events (CTCAE)","year":"2010"},{"issue":"32","key":"10.1016\/j.mayocp.2019.04.005_bib27","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.1200\/JCO.2007.12.4784","article-title":"Patient-reported outcomes and the evolution of adverse event reporting in oncology","volume":"25","author":"Trotti","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"issue":"17","key":"10.1016\/j.mayocp.2019.04.005_bib28","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1200\/JCO.2004.03.025","article-title":"How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the Quality-of-Life Questionnaire C30","volume":"22","author":"Fromme","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.04.005_bib29","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1007\/s11136-011-0031-4","article-title":"Reliability of adverse symptom event reporting by clinicians","volume":"21","author":"Atkinson","year":"2012","journal-title":"Qual Life Res"},{"issue":"9","key":"10.1016\/j.mayocp.2019.04.005_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jnci\/dju244","article-title":"Development of the national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"106","author":"Basch","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib31","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/jamaoncol.2015.2639","article-title":"Validity and reliability of the us national cancer institute\u2019s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE)","volume":"1","author":"Dueck","year":"2015","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.1016\/j.mayocp.2019.04.005_bib32","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/1097-0142(19870901)60:5<1151::AID-CNCR2820600538>3.0.CO;2-G","article-title":"The Memorial Pain Assessment Card. A valid instrument for the evaluation of cancer pain","volume":"60","author":"Fishman","year":"1987","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib33","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s11136-012-0344-y","article-title":"ISOQOL recommends minimum standards for patient-reported outcome measures used in patient-centered outcomes and comparative effectiveness research","volume":"22","author":"Reeve","year":"2013","journal-title":"Qual Life Res"},{"issue":"34","key":"10.1016\/j.mayocp.2019.04.005_bib34","doi-asserted-by":"crossref","first-page":"4249","DOI":"10.1200\/JCO.2012.42.5967","article-title":"Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology","volume":"30","author":"Basch","year":"2012","journal-title":"J\u00a0Clin Oncol"},{"issue":"15","key":"10.1016\/j.mayocp.2019.04.005_bib35","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1001\/jama.2012.466","article-title":"Methodological standards and patient-centeredness in comparative effectiveness research: the PCORI perspective","volume":"307","author":"Methodology Committee of the Patient-Centered Outcomes Research Institute","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib36","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1001\/jama.2013.879","article-title":"Reporting of patient-reported outcomes in randomized trials: the CONSORT PRO extension","volume":"309","author":"Calvert","year":"2013","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib37","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/S1470-2045(13)70493-5","article-title":"Health-related quality of life in small-cell lung cancer: a systematic review on reporting of methods and clinical issues in randomised controlled trials","volume":"15","author":"Zikos","year":"2014","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.04.005_bib38","doi-asserted-by":"crossref","first-page":"e294","DOI":"10.1016\/S1470-2045(16)30099-7","article-title":"Health-related quality of life in locally advanced and metastatic breast cancer: methodological and clinical issues in randomised controlled trials","volume":"17","author":"Ghislain","year":"2016","journal-title":"Lancet Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib39","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ejca.2003.10.012","article-title":"Methodological issues in assessing health-related quality of life of colorectal cancer patients in randomised controlled trials","volume":"40","author":"Efficace","year":"2004","journal-title":"Eur J Cancer"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib40","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cncr.11065","article-title":"Health related quality of life in prostate carcinoma patients: a systematic review of randomized controlled trials","volume":"97","author":"Efficace","year":"2003","journal-title":"Cancer"},{"issue":"14","key":"10.1016\/j.mayocp.2019.04.005_bib41","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/S0959-8049(02)00173-9","article-title":"Health related quality of life assessment methodology and reported outcomes in randomised controlled trials of primary brain cancer patients","volume":"38","author":"Efficace","year":"2002","journal-title":"Eur J Cancer"},{"issue":"23","key":"10.1016\/j.mayocp.2019.04.005_bib42","doi-asserted-by":"crossref","first-page":"4687","DOI":"10.1002\/cncr.30936","article-title":"Centralized patient-reported outcome data collection in transplantation is feasible and clinically meaningful","volume":"123","author":"Shaw","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.mayocp.2019.04.005_bib43","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1200\/JCO.2014.57.9334","article-title":"Symptomatic toxicities experienced during anticancer treatment: agreement between patient and physician reporting in three randomized trials","volume":"33","author":"Di Maio","year":"2015","journal-title":"J\u00a0Clin Oncol"},{"issue":"7","key":"10.1016\/j.mayocp.2019.04.005_bib44","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1158\/1078-0432.CCR-15-2035","article-title":"Focusing on core patient-reported outcomes in cancer clinical trials: symptomatic adverse events, physical function, and disease-related symptoms","volume":"22","author":"Kluetz","year":"2016","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.mayocp.2019.04.005_bib45","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/1472-6963-13-211","article-title":"A\u00a0systematic review of the impact of routine collection of patient reported outcome measures on patients, providers and health organisations in an oncologic setting","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Health Serv Res"},{"issue":"14","key":"10.1016\/j.mayocp.2019.04.005_bib46","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1200\/JCO.2013.53.5948","article-title":"What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials","volume":"32","author":"Kotronoulas","year":"2014","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib47","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.2017.7156","article-title":"Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment","volume":"318","author":"Basch","year":"2017","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mayocp.2019.04.005_bib48","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1200\/JCO.2004.06.078","article-title":"Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial","volume":"22","author":"Velikova","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"issue":"23","key":"10.1016\/j.mayocp.2019.04.005_bib49","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1001\/jama.288.23.3027","article-title":"Health-related quality-of-life assessments and patient-physician communication: a randomized controlled trial","volume":"288","author":"Detmar","year":"2002","journal-title":"JAMA"},{"issue":"9687","key":"10.1016\/j.mayocp.2019.04.005_bib50","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(09)61400-8","article-title":"Use of patient-reported outcomes in clinical practice","volume":"374","author":"Snyder","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.mayocp.2019.04.005_bib51","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1182\/asheducation-2015.1.501","article-title":"Patient-reported outcomes in clinical practice","volume":"2015","author":"Dobrozsi","year":"2015","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib52","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1080\/0284186X.2016.1268265","article-title":"Patient-reported outcomes in cancer survivorship","volume":"56","author":"Gordon","year":"2017","journal-title":"Acta Oncol"},{"issue":"8","key":"10.1016\/j.mayocp.2019.04.005_bib53","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s11136-011-0054-x","article-title":"Implementing patient-reported outcomes assessment in clinical practice: a review of the options and considerations","volume":"21","author":"Snyder","year":"2012","journal-title":"Qual Life Res"},{"issue":"2","key":"10.1016\/j.mayocp.2019.04.005_bib54","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1056\/NEJMp1611252","article-title":"Patient-reported outcomes - harnessing patients' voices to improve clinical care","volume":"376","author":"Basch","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mayocp.2019.04.005_bib55","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1200\/EDBK_200383","article-title":"Implementation of patient-reported outcomes in routine medical care","volume":"38","author":"Basch","year":"2018","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"1","key":"10.1016\/j.mayocp.2019.04.005_bib56","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1056\/NEJMp1702978","article-title":"Patient-reported outcomes \u2014 are they living up to their potential?","volume":"377","author":"Baumhauer","year":"2017","journal-title":"N\u00a0Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619303556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619619303556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:31:24Z","timestamp":1758418284000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619619303556"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":56,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S0025619619303556"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.04.005","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient Reported Outcomes Have Arrived: A Practical Overview for Clinicians in Using Patient Reported Outcomes in Oncology","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2019.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}